Struma ovarii risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{ARK}} | {{CMG}}; {{AE}} {{ARK}} | ||
==Overview== | ==Overview== | ||
Risk factors in the development of | Risk factors in the development of malignant struma ovarii from benign type include elevated [[CA-125]] levels, older age, [[postmenopausal]] status, and large tumor masses. | ||
==Risk Factors== | ==Risk Factors== | ||
*The most potent risk factors in the development of | *The most potent risk factors in the development of malignant struma ovarii from benign type are: <ref name="pmid26623411">{{cite journal |vauthors=Park CH, Jung MH, Ji YI |title=Risk factors for malignant transformation of mature cystic teratoma |journal=Obstet Gynecol Sci |volume=58 |issue=6 |pages=475–80 |year=2015 |pmid=26623411 |pmc=4663225 |doi=10.5468/ogs.2015.58.6.475 |url=}}</ref> | ||
:*Elevated [[CA-125]] levels | :*Elevated [[CA-125]] levels | ||
:*Older age (between 40 - 60 years) | :*Older age (between 40 - 60 years) | ||
Latest revision as of 02:30, 24 August 2017
|
Struma ovarii Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Struma ovarii risk factors On the Web |
|
American Roentgen Ray Society Images of Struma ovarii risk factors |
|
Risk calculators and risk factors for Struma ovarii risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Risk factors in the development of malignant struma ovarii from benign type include elevated CA-125 levels, older age, postmenopausal status, and large tumor masses.
Risk Factors
- The most potent risk factors in the development of malignant struma ovarii from benign type are: [1]
- Elevated CA-125 levels
- Older age (between 40 - 60 years)
- Large tumor masses
- Postmenopausal status
References
- ↑ Park CH, Jung MH, Ji YI (2015). "Risk factors for malignant transformation of mature cystic teratoma". Obstet Gynecol Sci. 58 (6): 475–80. doi:10.5468/ogs.2015.58.6.475. PMC 4663225. PMID 26623411.